437 results on '"Wraith, David C"'
Search Results
2. Symptoms and risk factors for long COVID in non-hospitalized adults
3. Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice
4. Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy
5. Designing antigens for the prevention and treatment of autoimmune diseases
6. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
7. Negative Selection during the Peripheral Immune Response to Antigen
8. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
9. The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care
10. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
11. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation
12. Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
13. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome
14. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
15. Adaptive T cell tuning in immune regulation and immunotherapy of autoimmune diseases✰
16. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire
17. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice
18. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
19. A Role for Galanin in Human and Experimental Inflammatory Demyelination
20. Enhanced Selection of FoxP3⁺ T-Regulatory Cells Protects CTLA-4-Deficient Mice from CNS Autoimmune Disease
21. In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
22. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength
23. Antigen-specific immunotherapy of autoimmune and allergic diseases
24. Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics
25. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
26. Preclinical models of arthritis for studying immunotherapy and immune tolerance
27. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy
28. A Single Amino Acid Change in a Myelin Basic Protein Peptide Confers the Capacity to Prevent Rather than Induce Experimental Autoimmune Encephalomyelitis
29. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
30. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases
31. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
32. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases
33. 2 Are mesenchymal stem cells immune privileged?
34. The adaptive immune system in diseases of the central nervous system
35. Antigen and Checkpoint Receptor Recalibration of T Cell Receptor Signal Strength
36. Peptide allergen‐specific immunotherapy for allergic airway diseases— State of the art
37. A LAT-Based Signaling Complex in the Immunological Synapse as Determined with Live Cell Imaging is Less Stable in T Cells with Regulatory Capability
38. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
39. Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and Duration
40. Vaccination and autoimmune disease: what is the evidence?
41. Peptide-based therapy for autoimmune diseases
42. IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE
43. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
44. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
45. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
46. Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome
47. Chromatin Priming Renders T Cell Tolerance-Associated Genes Sensitive to Activation below the Signaling Threshold for Immune Response Genes
48. SARS-CoV-2 seroconversion in health care workers
49. Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis
50. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.